Encompass Health
- Market cap
- 12.08B
- P/E (TTM)i
- 19.95
- P/Bi
- 4.65
- EPSi
- 5.54
- Div yieldi
- 0.62%
- 52W posi
- 86%
Anonymous reader poll. Unscientific, not investment advice.
Encompass Health shares were changing hands at 122.48, down 1.77% on the day. At current prices, the business is worth about 12.08B, the #1326 most valuable US-listed company we track. Trading at a P/E of 19.72, the stock is broadly in line with its own five-year norm of 20.45. It pays a dividend yielding 0.62% on a trailing basis. Wall Street's 10-analyst consensus lands on Buy, with a price target averaging 146.78 (+20% from here). The shares sit 86% of the way up their 52-week range of 92.25 to 127.28.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 2 days.
- Recent price momentum is +4.5% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 3.0% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation B
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 19.7x | Better than 48% |
| Forward P/E | 18.6x | Better than 46% |
| Price / Sales | 1.9x | Better than 65% |
| P/E vs own 5-yr range | 39th pctl | Better than 69% |
Growth A
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 10.9% | Better than 67% |
| Net income CAGR (3Y) | 27.8% | Better than 81% |
| Free cash flow CAGR (3Y) | 53.4% | Better than 87% |
Profitability A-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 95.7% | Better than 99% |
| Operating margin | 17.7% | Better than 58% |
| Net margin | 9.5% | Better than 44% |
| Return on equity | 25.1% | Better than 74% |
| Return on invested capital | 13.3% | Better than 68% |
Momentum B+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 9.3% | Better than 75% |
| 6-month return | 14.7% | Better than 64% |
| 12-month return (ex latest month) | -0.9% | Better than 30% |
| Distance below 52-week high | 5.0% | Better than 91% |
Financial Health C
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.1x | Better than 30% |
| Debt to assets | 38.3% | Better than 40% |
| Interest coverage | 8.7x | Better than 61% |
| Free cash flow / net income | 77.6% | Better than 24% |
Analyst View B+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 80% |
| Upside to average target | 21.3% | Better than 43% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 124.69
- Open
- 124.86
- Day range
- 121.99 - 125.55
- Avg price
- 122.89
- Volume
- 875.47K
- Turnover
- 107.59M
- Turnover ratei
- 0.90%
- Volume ratioi
- 0.82
- Amplitudei
- 2.86%
- 52-week rangei
- 92.25 - 127.28
Valuation
- P/Ei
- 22.11
- P/E (TTM)i
- 19.95
- P/Bi
- 4.65
- EPSi
- 5.54
- Book value / shi
- 26.33
- Net profit
- 546.54M
- Net assets
- 2.60B
Share structure
- Market cap
- 12.08B
- Float capi
- 11.96B
- Shares out
- 98.65M
- Float sharesi
- 97.65M
Dividend & listing
- Div yield (TTM)i
- 0.62%
- Dividend (TTM)
- 0.76
- Listing date
- 1970-01-01
3.8% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-127.23M net over the window
Short interest
- Shares short
- 3.00M
- % of floati
- 3.04%
- Days to coveri
- 4.12
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Encompass Health (EHC)?
Encompass Health last traded at 122.48. The quote on this page refreshes every few seconds while US markets are open.
What is Encompass Health's market cap?
About 12.08B.
What is the P/E ratio of Encompass Health?
The trailing twelve-month P/E is 19.95, below its own 5-year average of 20.45 — in the middle of its historical range (38.95% percentile). See the Valuation tab for the full history.
Does Encompass Health pay a dividend?
Yes. The trailing dividend yield is 0.62%. The 2025 payout was up 48.9% from 2024. See the Dividends tab for the full payment history.
Is Encompass Health a buy according to analysts?
The consensus of 10 analysts is a Buy rating, with an average 12-month price target of 146.78, which implies 19.8% upside from the current price. This is not investment advice.
What is Encompass Health's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Encompass Health a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-08 07:40:58 · For reference only, not investment advice and not tailored to your situation.